Life Biosciences Doses First Patient in FDA-Approved Gene Therapy Trial for Age-Related Blindness
By
Matthew Phelan
If you only eat one bagel today, this is the bagel.
Summary
Life Biosciences has dosed its first patient in an FDA-approved clinical trial testing a gene therapy designed to reverse cellular aging. The therapy targets glaucoma by aiming to regenerate aging neurons in the optic nerves, specifically retinal ganglion cells that typically die irreversibly in the condition. This marks a significant milestone in high-stakes human testing of anti-aging gene therapies.
Key quotes
· 3 pulledBuckle up. High-stakes human testing has now begun on a gene therapy that promises to reverse aging at the cellular level.
Life Biosciences's modest goal is to regenerate aging neurons in the optic nerves of patients struggling with glaucoma—a condition that often includes the irreversible death of neurons known as retinal ganglion cells.
the Boston-based longevity startup announced on Tuesday that it's just dosed its first patient
You might also wanna read

FDA Approves First Dual-AAV Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program
The FDA has approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy for trea
Method to reverse cellular ageing is about to be tested in humans
First In-Vivo Gene-Editing Therapy Successfully Saves Newborn's Life in 2025
In 2025, doctors and scientists in the U.S. successfully performed the world's first custom gene-editing therapy inside a living person—a ne
Clinical Trial Finds Ozempic Reverses Biological Age by 3.1 Years
The diabetes drug Ozempic has shown significant anti-aging effects in a clinical trial, reversing biological age by an average of 3.1 years
UCSF Researchers Identify FTL1 Protein as Key Factor in Brain Aging and Potential Reversal
Researchers at UC San Francisco have discovered that a protein called FTL1 plays a central role in brain aging. In mice studies, older anima
Stanford Researchers Develop Injection That Regenerates Knee Cartilage and Prevents Arthritis
Stanford Medicine researchers have developed an anti-aging injection that regenerates knee cartilage and prevents arthritis by blocking an a
